Overview

Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis

Status:
Completed

Trial end date:
1999-08-01

Target enrollment:

Participant gender:

Summary

OBJECTIVES: I. Compare the efficacy of enteric coated pancrelipase with bicarbonate (PANCRECARB) capsules versus the patient's usual enteric coated pancreatic enzyme without bicarbonate in decreasing fecal fat and nitrogen losses in patients with cystic fibrosis.

Phase:

N/A

Details

Lead Sponsor:

National Center for Research Resources (NCRR)

Collaborator:

Indiana University School of Medicine

Treatments:

Pancreatin
Pancrelipase